Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence

REV-ERBs, nuclear hormone receptors that regulate transcription as part of the circadian clock cell machinery, inhibit autophagy and lipogenesis in premalignant and malignant cells and impair tumour growth in vivo.